{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-011275","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2025-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.576072+00:00","generated_at":"2026-05-25T03:31:16.528094+00:00","sec_items":["5.03","5.05","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Sanuwave Health receives Nasdaq approval; trading expected to start March 7 under SNWV","bullets":["Common stock approved for listing on Nasdaq Global Market; trading begins March 7, 2025.","Ticker 'SNWV' unchanged from OTCQB; no stockholder action required.","Board approved amended bylaws including exclusive forum, proxy rules, and director cap increase to 10.","New Code of Business Conduct and Ethics adopted effective March 4, 2025.","CEO Morgan Frank cites 'transition and progress' and expects uplisting to drive shareholder value."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-011275","json":"https://secwatch.observer/filing/0001628280-25-011275.json","markdown":"https://secwatch.observer/filing/0001628280-25-011275.md","text":"https://secwatch.observer/filing/0001628280-25-011275.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000162828025011275/0001628280-25-011275-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000162828025011275/snwv-20250303.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T03:31:16.528094+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"224f168c4ac3e564aecd0fd40028a83f9a09671c","claim":"SANUWAVE Health, Inc.: Approve Amended and Restated Bylaws changing notice windows, special meeting prohibition, proxy color, board size, forum selection, and other administrative updates (effective 2025-03-04).","evidence_excerpt":"In connection with the Uplisting (as defined below), on March 4, 2025, the Board of Directors (the “Board”) of Sanuwave Health, Inc. (the “Company”) approved Amended and Restated Bylaws of the Company (the “A&R Bylaws”), which amend and restate the Company’s existing bylaws (the “Existing Bylaws”) in their entirety.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000162828025011275/0001628280-25-011275-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2025-03-04"}],"fact_type":"governance_change"},{"claim_id":"653d6d6df68037a4bb0952841a38fb77ac9c9c95","claim":"SANUWAVE Health, Inc.: Approved a new Code of Business Conduct and Ethics (effective 2025-03-04).","evidence_excerpt":"In connection with the Uplisting, on March 4, 2025, the Board approved a new Code of Business Conduct and Ethics.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000162828025011275/0001628280-25-011275-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"code of ethics"},{"label":"Effective","value":"2025-03-04"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}